Terug
Ook genoteerd als
IMBBY
OTC
Dagbereik
€ 40,30
€ 41,97
52-Weeksbereik
€ 34,82
€ 47,18
Volume
113
50D / 200D Gem.
€ 42,93
/
€ 41,66
Vorige Slotkoers
€ 39,83
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Defensive sector mediaan (329 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 15,6 | 10,4 |
| P/B | 6,7 | 1,3 |
| ROE % | 40,4 | 12,3 |
| Net Margin % | 6,4 | 5,3 |
| Rev Growth 5Y % | -0,5 | 5,5 |
| D/E | 2,1 | 0,6 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 4,67
€ 4,55 – € 4,76
|
10,90B | 1 |
| FY2028 |
€ 4,15
€ 4,05 – € 4,23
|
10,44B | 1 |
| FY2027 |
€ 3,75
€ 3,65 – € 3,82
|
10,28B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-11-18 | € 2,55 | € 2,05 | -19,6% |
| 2025-05-13 | € 1,61 | € 1,24 | -23,0% |
| 2024-11-19 | € 2,32 | € 2,72 | +17,2% |
| 2024-05-15 | € 1,48 | € 1,20 | -18,9% |
| 2024-01-31 | € 1,97 | € 1,64 | -16,8% |
| 2023-03-31 | € 1,47 | € 1,43 | -2,7% |
| 2022-09-30 | € 1,66 | € 0,66 | -60,0% |
| 2022-03-31 | € 1,42 | € 1,36 | -4,2% |
Dividend History
7 yr streakYield
0,06%
Payout Ratio
0,75%
Growth (3Y)
8,97%
Growth (5Y)
1,82%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Feb 20, 2026 | Mar 31, 2026 | € 0,54 | 4,82% |
| Nov 28, 2025 | Dec 31, 2025 | € 0,53 | 5,17% |
| Aug 22, 2025 | Sep 30, 2025 | € 0,54 | 5,64% |
| May 23, 2025 | Jun 30, 2025 | € 0,54 | 5,80% |
| Feb 21, 2025 | Mar 31, 2025 | € 0,69 | 5,63% |
| Nov 29, 2024 | Dec 31, 2024 | € 0,69 | 5,72% |
| Aug 23, 2024 | Sep 30, 2024 | € 0,30 | 6,40% |
| May 23, 2024 | Jun 28, 2024 | € 0,29 | 7,26% |
| Feb 15, 2024 | Mar 28, 2024 | € 0,65 | 7,87% |
| Nov 23, 2023 | Dec 29, 2023 | € 0,65 | 7,30% |
| Aug 17, 2023 | Sep 29, 2023 | € 0,28 | 7,65% |
| May 25, 2023 | Jun 30, 2023 | € 0,27 | 7,74% |
| Feb 16, 2023 | Mar 31, 2023 | € 0,59 | 7,13% |
| Nov 24, 2022 | Dec 30, 2022 | € 0,60 | 7,11% |
| Aug 18, 2022 | Sep 30, 2022 | € 0,25 | 8,33% |
| May 26, 2022 | Jun 30, 2022 | € 0,27 | 8,37% |
| Feb 17, 2022 | Mar 31, 2022 | € 0,66 | 8,07% |
| Nov 25, 2021 | Dec 31, 2021 | € 0,65 | 9,23% |
| Aug 19, 2021 | Sep 30, 2021 | € 0,29 | 8,15% |
| May 27, 2021 | Jun 30, 2021 | € 0,30 | 6,96% |
Belangrijkste Punten
Revenue declined -0,48% annually over 5 years
Earnings declined -20,74% over the past year
ROE of 40,35% indicates high profitability
Debt/Equity of 2,07 — high leverage
Generating 2,86B in free cash flow
Cash machine — converts 138,05% of earnings into free cash flow
Groei
Revenue Growth (5Y)
-0,48%
Revenue (1Y)-0,74%
Earnings (1Y)-20,74%
FCF Growth (3Y)-1,49%
Kwaliteit
Return on Equity
40,35%
ROIC17,66%
Net Margin6,44%
Op. Margin10,85%
Veiligheid
Debt / Equity
2,07
Current Ratio0,74
Interest Coverage7,65
Waardering
P/E Ratio
15,57
Forward P/E12,30
P/B Ratio6,69
EV/EBITDA11,70
Dividend Yield0,06%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,74% | Revenue Growth (3Y) | -0,47% |
| Earnings Growth (1Y) | -20,74% | Earnings Growth (3Y) | -5,68% |
| Revenue Growth (5Y) | -0,48% | Earnings Growth (5Y) | -7,54% |
| Profitability | |||
| Revenue (TTM) | 32,17B | Net Income (TTM) | 2,07B |
| ROE | 40,35% | ROA | 7,21% |
| Gross Margin | 21,76% | Operating Margin | 10,85% |
| Net Margin | 6,44% | Free Cash Flow (TTM) | 2,86B |
| ROIC | 17,66% | FCF Growth (3Y) | -1,49% |
| Safety | |||
| Debt / Equity | 2,07 | Current Ratio | 0,74 |
| Interest Coverage | 7,65 | ||
| Dividends | |||
| Dividend Yield | 0,06% | Payout Ratio | 0,75% |
| Dividend Growth (3Y) | 8,97% | Dividend Growth (5Y) | 1,82% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 15,57 | Forward P/E | 12,30 |
| P/B Ratio | 6,69 | P/S Ratio | 1,00 |
| PEG Ratio | -0,77 | Forward PEG | N/A |
| EV/EBITDA | 11,70 | Fwd EV/EBITDA | 24,82 |
| Forward P/S | 3,20 | Fwd Earnings Yield | 8,13% |
| FCF Yield | 8,87% | ||
| Market Cap | 32,25B | Enterprise Value | 40,81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 32,17B | 32,41B | 32,48B | 32,55B | 32,79B |
| Net Income | 2,07B | 2,61B | 2,33B | 1,57B | 2,83B |
| EPS (Diluted) | 2,49 | 2,99 | 2,51 | 1,65 | 2,99 |
| Gross Profit | 7,00B | 6,78B | 6,68B | 6,04B | 6,03B |
| Operating Income | 3,49B | 3,55B | 3,40B | 3,35B | 3,15B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 28,72B | 27,83B | 29,49B | 30,96B | 29,09B |
| Total Liabilities | 23,28B | 21,80B | 22,85B | 23,49B | 23,15B |
| Shareholders' Equity | 4,82B | 5,44B | 6,02B | 6,86B | 5,35B |
| Total Debt | 10,00B | 9,08B | 9,73B | 10,26B | 10,07B |
| Cash & Equivalents | 1,44B | 1,08B | 1,35B | 1,85B | 1,29B |
| Current Assets | 8,81B | 8,20B | 8,60B | 8,92B | 8,21B |
| Current Liabilities | 11,85B | 11,46B | 11,90B | 11,14B | 10,81B |
Strategiescores
This stock passed the criteria for 0 strategies
Score = fit strength (0–100)
Rank = position among all matches
Recente Activiteit
Uitgestapt
Contrarian Investing (David Dreman)
Mar 26, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026